To enable us to maintain the highest scientific standards and improve the questionnaire component when planning future programs, please complete the Evaluation Form and Self Assessment.

Fields marked with an asterisk (*) are required.

Prefix:
Other (please specify)
*First Name:
MI:
*Last Name:
*Degree(s):
(check all that apply)
MD DO PhD
BS MS RN
Other (please specify)
*Specialty:
Other (please specify)
Years in Practice:
*Affiliation:
Department:
*Practice type:
Other (please specify)
Address:
Business Personal
Address name:
*Address 1:
Address 2:
*City:
*State:
*ZIP:
*Daytime Telephone: (eg, xxx-xxx-xxxx)
Extension:
Fax: (eg, xxx-xxx-xxxx)
*E-mail:
Best time to contact:

This activity is supported by an independent educational grant provided by

Privacy Policy
We value the confidentiality of the information you choose to share with us and are committed to its protection. All personal information you provide is stored in a secure location and will never be sold or distributed to any third party.

EVALUATION

The Monograph
 
AgreeDisagree
5 4 3 2 1
*Met my expectations:
*Was relevant to my clinical practice:
*Will influence how I practice:
*Will help me improve patient care:
*Stimulated my intellectual curiosity:

After participating in this activity, I will change my clinical practice by:
Additional comments:

SELF ASSESSMENT

*1. Why is the clinical laboratory definition of hypogonadism inadequate in making a complete diagnosis?
Physicians cannot agree on an appropriate unit of measure for serum testosterone levels
Laboratory assays are standardized, resulting in inter-rater variability among laboratory technicians
Relying on a single threshold level of testosterone may identify patients with low testosterone levels but without significant symptoms of hypogonadism
Screening questionnaires are more accurate than laboratory assays
*2. Potential benefits of testosterone therapy in testosterone-deficient adult men include
Restored libido and erectile function
Increased energy and improved mood
Stabilized or increased bone density
All of the above
*3. The link between low testosterone levels and insulin resistance suggests that:
Testosterone therapy may increase insulin resistance in men with diabetes and hypogonadism
Testosterone therapy may reduce insulin resistance in men with diabetes and hypogonadism
Androgen-deprivation therapy may reduce insulin resistance in men with diabetes and hypogonadism
Androgen-deprivation therapy may increase insulin resistance in men with diabetes and hypogonadism
*4. Studies suggest that hypogonadism is strongly associated with the development and presence of metabolic syndrome:
True
False
*5. When choosing a testosterone formulation, which of the following factors should be considered?
Safety relative to the patient's medical profile
Tolerability of the mode of administration
Characteristics of efficacy
All of the above
*6. Dosing frequency of a long-acting intramuscular injection of testosterone undecanoate will likely be:
4 injections/year
12 injections/year
26 injections/year
52 injections/year